Myelofibrosis (combo w/ ruxolitinib)| XPORT-MF-034
Indication: Myelofibrosis
Title: A Study to Evaluate Safety and Efficacy of Selinexor in Combination With Ruxolitinib in Participants With Myelofibrosis
Drug: Selinexor
Please Visit clinicaltrials.gov for more information about this study.
Phase 1 | Phase 2 | Phase 3 | Commercial |
---|---|---|---|
Phase 1 | Phase 2 | Phase 3 | Commercial |